News for Lifecore Biomedical Inc Stock (LFCR)

IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 16h

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

PRNewsWire • Monday

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCR

PRNewsWire • 04/20/24

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

PRNewsWire • 04/20/24

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report

GlobeNewsWire • 04/19/24

LFCR INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

PRNewsWire • 04/13/24

ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC

Business Wire • 04/11/24

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 04/11/24

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 04/08/24

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 04/05/24

ONGOING SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 04/04/24

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 03/29/24

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors

Business Wire • 03/28/24

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors

Business Wire • 03/28/24

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Business Wire • 03/28/24

The Law Offices of Frank R. Cruz Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors

Business Wire • 03/27/24

Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update

GlobeNewsWire • 03/26/24

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lifecore Biomedical, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 03/25/24

Lifecore Class Action Lawsuit Investigation News – Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLP

Business Wire • 03/24/24

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR)

Business Wire • 03/21/24

Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal

Zacks Investment Research • 03/21/24

Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes

GlobeNewsWire • 03/20/24

Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023

GlobeNewsWire • 03/20/24

Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal

GlobeNewsWire • 02/16/24

Strength Seen in Lifecore Biomedical (LFCR): Can Its 16.0% Jump Turn into More Strength?

Zacks Investment Research • 02/06/24